Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Lee CK, Davies L, Wu YL, Mitsudomi T, Inoue A, Rosell R, Zhou C, Nakagawa K, Thongprasert S, Fukuoka M, Lord S, Marschner I, Tu YK, Gralla RJ, Gebski V, Mok T, Yang JC.
Lee CK, et al. Among authors: gebski v.
J Natl Cancer Inst. 2017 Jun 1;109(6). doi: 10.1093/jnci/djw279.
J Natl Cancer Inst. 2017.
PMID: 28376144
Review.